Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AAKHI, absence, bundled, comparison, dedesignated, dialyzer, disease, EVO, fourth, health, Indenture, IQ, Mellon, necessitating, PrisMax, proposed, prosecution, repaid, stage, strong, Trust, Trustee, Twelfth
Removed:
adjusted, arising, core, improved, initiated, moving, nonstrategic, presenting, salary, unrecognized
Filing tables
Filing exhibits
Related press release
Associated BAX transcripts
BAX similar filings
Filing view
External links
EXHIBIT 15
July 30, 2019
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We are aware that our report dated July 30, 2019 on our review of interim financial information of Baxter International Inc., which appears in this Quarterly Report on Form 10-Q, is incorporated by reference in the Registration Statements on Form S-8 (Nos. 33-28428, 33-54069, 333-10520, 333-43563, 333-47019, 333-71553, 333-80403, 333-88257, 333-48906, 333-62820, 333-102140, 333-104420, 333-104421, 333-105032, 333-143063, 333-174400, 333-174401, 333-206700 and 333-206701) and on Form S-3 (No. 333-226987) of Baxter International Inc.
Very truly yours,
/s/ PricewaterhouseCoopers LLP
Chicago, Illinois